JERYL L HILLEMAN Insider Trading $NVCR NovoCure Ltd

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JERYL L HILLEMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JERYL L HILLEMAN. JERYL L HILLEMAN is Exec. Vice President and CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Senior Vice President & CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Sr. Vice President and CFO in SYMYX TECHNOLOGIES INC ($SMMX) and Director in XENOPORT INC ($XNPT) and Chief Financial Officer in Intersect ENT, Inc. ($XENT) and in SI-BONE, Inc. ($SIBN) and Director in Talis Biomedical Corp ($TLIS) and Director in Minerva Neurosciences, Inc. ($NERV) and Director in NovoCure Ltd ($NVCR).

JERYL L HILLEMAN in NovoCure Ltd

Trading Symbol: NVCR
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JERYL L HILLEMAN: Director
Holdings: 3,400 shares
Current Value: $23,120
Latest Transaction: Dec 22 2020
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JERYL L HILLEMAN in NovoCure Ltd

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, XENT, NERV, NVCR, SIBN, SMMX, TLIS, XNPT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 22 2020NVCRNovoCure LtdHILLEMAN JERYL LDirectorSellS166.402,500416,0003,4005.9 K to 3.4 K (-42.37 %)
Jun 12 2020NVCRNovoCure LtdHILLEMAN JERYL LDirectorOption ExerciseA67.895,101346,3075,101
Jun 12 2020NVCRNovoCure LtdHILLEMAN JERYL LDirectorGrantA0.002,54105,9003.4 K to 5.9 K (+75.65 %)
May 24 2019NVCRNovoCure LtdHILLEMAN JERYL LDirectorOption ExerciseA51.366,340325,6226,340
May 24 2019NVCRNovoCure LtdHILLEMAN JERYL LDirectorGrantA0.003,35903,3590 to 3.4 K
Aug 02 2018NVCRNovoCure LtdHILLEMAN JERYL LDirectorOption ExerciseA34.0037,1011,261,43437,101

Page:   1